Article info
Human glioma cells transformed by IGF-I triple helix technology show immune and apoptotic characteristics determining cell selection for gene therapy of glioblastoma
- Dr Trojan, Lab. Neurologie du Développement, INSERM E9935& Univ. Paris VII, Hôpital Robert Debré, 48, Bd. Sérurier, 75019 Paris, France JerzyTrojan{at}compuserve.com
Citation
Human glioma cells transformed by IGF-I triple helix technology show immune and apoptotic characteristics determining cell selection for gene therapy of glioblastoma
Publication history
- Accepted March 8, 2001
- First published August 1, 2001.
Online issue publication
August 01, 2001
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
COPYRIGHT © 2001 Journal of Clinical Pathology